+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Cartilage Repair/Cartilage Regeneration Market by Repair Technique, Targeted Site, Material Type, Source Type, Application, End-Users - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 182 Pages
  • March 2025
  • Region: Global
  • 360iResearch™
  • ID: 5201077
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Cartilage Repair/Cartilage Regeneration Market grew from USD 1.91 billion in 2024 to USD 2.09 billion in 2025. It is expected to continue growing at a CAGR of 10.49%, reaching USD 3.48 billion by 2030.

The field of cartilage repair and regeneration has rapidly transformed into one of the most promising arenas in modern medicine. Medical professionals, researchers, and industry decision-makers are increasingly focused on innovative techniques that restore function and enhance patients’ quality of life. Over recent years, technological advancements in biomedical engineering, a deeper understanding of cellular mechanisms, and breakthroughs in material science have driven a notable shift in how cartilage injuries are addressed. This market not only supports therapeutic innovations that promise safer and more effective treatment outcomes, but it also provides a competitive platform for emerging technologies that aim to lower patient recovery time while reducing complications.

Constant evolution in clinical practices, supported by regulatory advancements and refined scientific protocols, has contributed to a robust and dynamic market environment. As practitioners pivot from traditional surgical interventions to novel regenerative strategies, stakeholders have observed an increase in investment in research and development. This well-established progression boosts clinical outcomes and underpins commercial growth. In addition, the integration of interdisciplinary approaches, combining orthopedics, biomaterials, and cellular biology, ensures that each new development adds more value to both patient care and overall market sustainability.

Transformative Shifts in the Cartilage Repair Arena

Recent transformative shifts in the cartilage repair arena have established a new benchmark for medical innovation. Developers have harnessed advanced biotechnologies to refine previous methods, reshaping treatment protocols with higher precision and improved long-term results. The adoption of novel biomaterials, augmented imaging techniques, and minimally invasive procedures all contribute to a paradigm where restoration is more targeted, efficient, and less burdensome for patients.

Technological convergence has been pivotal: from digital radiography guiding surgical precision to molecular biology techniques that enable personalized regenerative therapies, this revolution is underpinned by a collaborative effort between research institutes and clinical practitioners. As a result, novel paradigms such as the integration of stem cell therapies and tissue engineering are steadily becoming central to treatment plans. Enhanced desirability of these techniques is largely attributed to their robust clinical outcomes and the promise of restoring joint function more naturally. Investors and industry executives alike now view cartilage repair not just as a standalone field but as a multifaceted service capable of addressing a broad spectrum of musculoskeletal disorders. Overall, these shifts are not merely incremental improvements but are, in fact, setting the stage for an industry-wide redefinition of healing and recovery.

Key Segmentation Insights in Cartilage Repair/Regeneration

A closer look into market segmentation reveals a detailed and layered landscape that caters to a variety of treatment modalities and clinical applications. Within the realm of repair techniques, the analysis covers established procedures such as Autologous Chondrocyte Implantation, Chondroplasty, Microfracture, Mosaicplasty, and Osteochondral Autograft Transplantation, while also exploring cutting-edge methods including Stem Cell-Based Cartilage Regeneration and Tissue Engineering. When examining stem cell-based methods, scrutiny is applied to both adult and embryonic stem cells, offering insight into the nuances and development potential of these therapies. Similarly, the Tissue Engineering segment is dissected into cell-based and scaffold-based techniques, each with unique advantages that shape clinical decisions.

Apart from procedural approaches, segmentation extends into targeted anatomical sites including the ankle, elbow, hip, knee, and shoulder cartilages. This geographical focus within the human body enables practitioners to tailor interventions on a site-specific basis. Material type segmentation further divides the market through the use of natural biomaterials, such as those based on chitosan, collagen, and hyaluronic acid, contrasted with synthetic biomaterials like polyethylene glycol and polylactic acid. Additional segmentation by source type, distinguishing allogeneic from autologous materials, further refines the selection process. Moreover, segmentation based on clinical application distinguishes between elastic, fibrocartilage, and hyaline cartilage repair, while end-user analysis focuses on settings that span ambulatory surgical centers, hospitals, and orthopedic clinics. Together, these segmentation strategies create a comprehensive framework for assessing market trends and driving clinical innovation.

Based on Repair Technique, market is studied across Autologous Chondrocyte Implantation (ACI), Chondroplasty, Microfracture, Mosaicplasty, Osteochondral Autograft Transplantation (OAT), Stem Cell-Based Cartilage Regeneration, and Tissue Engineering. The Stem Cell-Based Cartilage Regeneration is further studied across Adult Stem Cells and Embryonic Stem Cells. The Tissue Engineering is further studied across Cell-Based Techniques and Scaffold-Based Techniques.

Based on Targeted Site, market is studied across Ankle Cartilage, Elbow Cartilage, Hip Cartilage, Knee Cartilage, and Shoulder Cartilage.

Based on Material Type, market is studied across Natural Biomaterials and Synthetic Biomaterials. The Natural Biomaterials is further studied across Chitosan-Based, Collagen-Based, and Hyaluronic Acid-Based. The Synthetic Biomaterials is further studied across Polyethylene Glycol (PEG) and Polylactic Acid (PLA).

Based on Source Type, market is studied across Allogeneic and Autologous.

Based on Application, market is studied across Elastic Cartilage Repair, Fibrocartilage Repair, and Hyaline Cartilage Repair.

Based on End-Users, market is studied across Ambulatory Surgical Centers, Hospitals, and Orthopedic Clinics.

Key Regional Insights Shaping Market Trends

A regional dissection of the market unveils distinct trends and growth opportunities across different parts of the world. In the Americas, robust healthcare infrastructures combined with significant investment in R&D have fostered rapid adoption of advanced cartilage repair techniques. The emphasis on precision medicine and clinical excellence drives market expansion in this region, supported by a strong network of academic and medical institutions.

In Europe, the Middle East & Africa, the evolving regulatory landscape and emphasis on collaborative public-private initiatives bolster research and development efforts. The market in these regions is characterized by steady growth rates and an increasing number of clinical trials aimed at optimizing regenerative therapies. Lastly, the Asia-Pacific region presents a dynamic growth environment, where increasing healthcare expenditure and a surge in innovation-oriented government policies are contributing to an accelerating acceptance of state-of-the-art cartilage repair and regeneration techniques. This diverse regional perspective underlines how localized factors and healthcare dynamics influence the broader market trajectory.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Insights Driving Innovations

Market leadership in cartilage repair and regeneration is driven by a blend of established giants and nimble innovators continually pushing the envelope of what is clinically possible. Noteworthy companies such as Anika Therapeutics Inc. and Arthrex, Inc. have carved niches in delivering high-quality surgical products that are frequently at the frontline of innovation. B. Braun SE and BioTissue, Inc. further contribute to a landscape that is rapidly evolving by integrating robust production methods with cutting-edge clinical applications.

Other market players, including Bioventus, Collagen Solutions Ltd., and CollPlant Biotechnologies Ltd., have made significant strides in product development by leveraging unique biomaterial solutions and personalized treatment approaches. Leading the charge, CONMED Corporation, Episurf Medical AB, and Geistlich Pharma AG consistently introduce improvements that cater to both patient outcomes and operational efficiencies in clinical settings. The contributions of Integra LifeSciences Corporation, Isto Biologics Inc, Johnson & Johnson Services, Inc., and Kolon TissueGene, Inc. underscore the importance of diversified portfolios that merge clinical performance with innovative design. In addition, companies such as MEDIPOST Co., Ltd., Mesoblast Limited, Ocugen, Inc., Orthocell Ltd., Regrow Biosciences Pvt Ltd., RTI Surgical, Inc., Smith & Nephew PLC, Stryker Corporation, Vericel Corporation, and Zimmer Biomet Holdings, Inc. round out a vibrant market picture where both established and emerging players drive sustained innovation and market expansion.

The report delves into recent significant developments in the Cartilage Repair/Cartilage Regeneration Market, highlighting leading vendors and their innovative profiles. These include Anika Therapeutics Inc., Arthrex, Inc., B. Braun SE, BioTissue, Inc., Bioventus, Collagen Solutions Ltd., CollPlant Biotechnologies Ltd., CONMED Corporation, Episurf Medical AB, Geistlich Pharma AG, Integra LifeSciences Corporation, Isto Biologics Inc, Johnson & Johnson Services, Inc., Kolon TissueGene, Inc., MEDIPOST Co., Ltd., Mesoblast Limited, Ocugen, Inc., Orthocell Ltd., Regrow Biosciences Pvt Ltd., RTI Surgical, Inc., Smith & Nephew PLC, Stryker Corporation, Vericel Corporation, and Zimmer Biomet Holdings, Inc..

Actionable Recommendations for Industry Leaders

For industry leaders seeking to navigate the evolving landscape of cartilage repair and regeneration, several actionable recommendations emerge from current market insights. First, a sustained focus on investing in research and development is essential to remain competitive. Embracing innovations in stem cell therapies, tissue engineering, and novel biomaterials can open new avenues for differentiation, leading to superior clinical outcomes and market positioning.

Leaders should also consider strategic collaborations with academic institutions and technology partners to accelerate product delivery and scale innovative solutions. Allocating resources to clinical trials and real-world evidence studies provides a stronger basis for regulatory approvals and market confidence. Furthermore, tailoring offerings based on specific segmentation criteria such as targeted anatomical sites, material types, and repair techniques will ensure that products meet the diverse needs of practitioners and patients alike. Finally, expanding outreach through region-specific strategies can harness the unique growth drivers inherent in areas like the Americas, Europe, the Middle East & Africa, and the Asia-Pacific. These combined approaches empower decision-makers to not only respond to market trends but also to shape the future trajectory of cartilage repair technologies.

Strategic Outlook and Future Directions

In summary, the evolution of cartilage repair and regeneration represents a confluence of technological, clinical, and market dynamics that signal promising growth ahead. The convergence of innovative repair techniques, evolving segmentation strategies, and diverse regional growth patterns creates an environment ripe for both incremental and radical advancements. As market leaders continue to invest in cutting-edge therapies and robust research initiatives, the future of cartilage regeneration is poised to redefine clinical practices worldwide.

The strategic interplay between established treatment modalities and burgeoning regenerative technologies reinforces a resilient market outlook, one that benefits patients through improved clinical outcomes and reduced recovery times. The synthesis of forward-thinking strategies and collaborative initiatives will drive sustained growth and cement the market’s role as a cornerstone of modern regenerative medicine.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing number of individuals participating in sports and physical activities
5.1.1.2. Increasing the prevalence of degenerative joint diseases worldwide
5.1.1.3. Rising awareness of cartilage-related conditions and improvements in diagnostic technology
5.1.2. Restraints
5.1.2.1. High cost of treatments for cartilage repair and regeneration
5.1.3. Opportunities
5.1.3.1. Adoption of 3D bioprinting technologies to create customized cartilage implants
5.1.3.2. Supportive governments funding and incentives for research and development of advanced medical treatments
5.1.4. Challenges
5.1.4.1. Risk of postoperative complications and long-term side effects associated with certain cartilage repair procedures
5.2. Market Segmentation Analysis
5.2.1. Repair Technique: Rising preference for autologous chondrocyte implantation for treating cartilage defects
5.2.2. End-Users: Growing expansion in the fibrocartilage repair to address the menisci and intervertebral discs
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Cartilage Repair/Cartilage Regeneration Market, by Repair Technique
6.1. Introduction
6.2. Autologous Chondrocyte Implantation (ACI)
6.3. Chondroplasty
6.4. Microfracture
6.5. Mosaicplasty
6.6. Osteochondral Autograft Transplantation (OAT)
6.7. Stem Cell-Based Cartilage Regeneration
6.7.1. Adult Stem Cells
6.7.2. Embryonic Stem Cells
6.8. Tissue Engineering
6.8.1. Cell-Based Techniques
6.8.2. Scaffold-Based Techniques
7. Cartilage Repair/Cartilage Regeneration Market, by Targeted Site
7.1. Introduction
7.2. Ankle Cartilage
7.3. Elbow Cartilage
7.4. Hip Cartilage
7.5. Knee Cartilage
7.6. Shoulder Cartilage
8. Cartilage Repair/Cartilage Regeneration Market, by Material Type
8.1. Introduction
8.2. Natural Biomaterials
8.2.1. Chitosan-Based
8.2.2. Collagen-Based
8.2.3. Hyaluronic Acid-Based
8.3. Synthetic Biomaterials
8.3.1. Polyethylene Glycol (PEG)
8.3.2. Polylactic Acid (PLA)
9. Cartilage Repair/Cartilage Regeneration Market, by Source Type
9.1. Introduction
9.2. Allogeneic
9.3. Autologous
10. Cartilage Repair/Cartilage Regeneration Market, by Application
10.1. Introduction
10.2. Elastic Cartilage Repair
10.3. Fibrocartilage Repair
10.4. Hyaline Cartilage Repair
11. Cartilage Repair/Cartilage Regeneration Market, by End-Users
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.3. Hospitals
11.4. Orthopedic Clinics
12. Americas Cartilage Repair/Cartilage Regeneration Market
12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States
13. Asia-Pacific Cartilage Repair/Cartilage Regeneration Market
13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam
14. Europe, Middle East & Africa Cartilage Repair/Cartilage Regeneration Market
14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Scenario Analysis
15.3.1. CO.DON GmbH leverages three decades of regenerative medicine expertise to drive advanced 3D bioprinting and cartilage repair innovations
15.3.2. Faculty of Medicine at University of Helsinki launches transformative 3D bioprinting initiative to develop personalized bone and cartilage regeneration treatments
15.3.3. CytexOrtho advances revolutionary cartilage repair with FDA-approved first-in-human trials for its ReNew Hip Implant
15.3.4. Northwestern University pioneers future of cartilage regeneration and joint repair
15.3.5. Altach secures EUR 1.2 million investment to revolutionize cartilage repair with innovative collagen scaffold
15.3.6. Smith+Nephew's acquires CartiHeal to enhance their sports medicine portfolio
15.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET MULTI-CURRENCY
FIGURE 2. CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET MULTI-LANGUAGE
FIGURE 3. CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET RESEARCH PROCESS
FIGURE 4. CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, 2024 VS 2030
FIGURE 5. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 6. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2024 VS 2030 (%)
FIGURE 9. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2024 VS 2030 (%)
FIGURE 11. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2030 (%)
FIGURE 13. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2024 VS 2030 (%)
FIGURE 15. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 16. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 17. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 18. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2024 VS 2030 (%)
FIGURE 19. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 20. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 21. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 22. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 23. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 24. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 25. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 27. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 28. CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 29. CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET DYNAMICS
TABLE 7. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY AUTOLOGOUS CHONDROCYTE IMPLANTATION (ACI), BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CHONDROPLASTY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MICROFRACTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MOSAICPLASTY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY OSTEOCHONDRAL AUTOGRAFT TRANSPLANTATION (OAT), BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY ADULT STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY EMBRYONIC STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SCAFFOLD-BASED TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY ANKLE CARTILAGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY ELBOW CARTILAGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY HIP CARTILAGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY KNEE CARTILAGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SHOULDER CARTILAGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CHITOSAN-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COLLAGEN-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY HYALURONIC ACID-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY POLYETHYLENE GLYCOL (PEG), BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY POLYLACTIC ACID (PLA), BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY ALLOGENEIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY AUTOLOGOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY ELASTIC CARTILAGE REPAIR, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY FIBROCARTILAGE REPAIR, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY HYALINE CARTILAGE REPAIR, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY ORTHOPEDIC CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 59. ARGENTINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 60. ARGENTINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
TABLE 61. ARGENTINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 62. ARGENTINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2018-2030 (USD MILLION)
TABLE 63. ARGENTINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 64. ARGENTINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 65. ARGENTINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 66. ARGENTINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
TABLE 67. ARGENTINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. ARGENTINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 79. CANADA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 80. CANADA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
TABLE 81. CANADA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 82. CANADA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2018-2030 (USD MILLION)
TABLE 83. CANADA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 84. CANADA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 85. CANADA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 86. CANADA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
TABLE 87. CANADA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. CANADA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 89. MEXICO CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 90. MEXICO CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
TABLE 91. MEXICO CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 92. MEXICO CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2018-2030 (USD MILLION)
TABLE 93. MEXICO CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 94. MEXICO CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 95. MEXICO CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 96. MEXICO CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
TABLE 97. MEXICO CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. MEXICO CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 102. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2018-2030 (USD MILLION)
TABLE 103. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 104. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 105. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 106. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
TABLE 107. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 109. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 110. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 111. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
TABLE 112. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 113. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2018-2030 (USD MILLION)
TABLE 114. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 115. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 116. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 117. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
TABLE 118. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 120. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 121. AUSTRALIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 122. AUSTRALIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
TABLE 123. AUSTRALIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 124. AUSTRALIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2018-2030 (USD MILLION)
TABLE 125. AUSTRALIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 126. AUSTRALIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 127. AUSTRALIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 128. AUSTRALIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
TABLE 129. AUSTRALIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. AUSTRALIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 131. CHINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 132. CHINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
TABLE 133. CHINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 134. CHINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2018-2030 (USD MILLION)
TABLE 135. CHINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 136. CHINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 137. CHINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 138. CHINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
TABLE 139. CHINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. CHINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 141. INDIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 142. INDIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
TABLE 143. INDIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 144. INDIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2018-2030 (USD MILLION)
TABLE 145. INDIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 146. INDIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 147. INDIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 148. INDIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
TABLE 149. INDIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 150. INDIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 151. INDONESIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 152. INDONESIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
TABLE 153. INDONESIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 154. INDONESIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2018-2030 (USD MILLION)
TABLE 155. INDONESIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 156. INDONESIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 157. INDONESIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 158. INDONESIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
TABLE 159. INDONESIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 160. INDONESIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 161. JAPAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 162. JAPAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
TABLE 163. JAPAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 164. JAPAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2018-2030 (USD MILLION)
TABLE 165. JAPAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 166. JAPAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 167. JAPAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 168. JAPAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
TABLE 169. JAPAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 170. JAPAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 171. MALAYSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 172. MALAYSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
TABLE 173. MALAYSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 174. MALAYSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2018-2030 (USD MILLION)
TABLE 175. MALAYSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 176. MALAYSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 177. MALAYSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 178. MALAYSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
TABLE 179. MALAYSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 180. MALAYSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 181. PHILIPPINES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 182. PHILIPPINES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
TABLE 183. PHILIPPINES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 184. PHILIPPINES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2018-2030 (USD MILLION)
TABLE 185. PHILIPPINES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 186. PHILIPPINES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 187. PHILIPPINES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 188. PHILIPPINES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
TABLE 189. PHILIPPINES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 190. PHILIPPINES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 191. SINGAPORE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 192. SINGAPORE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
TABLE 193. SINGAPORE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 194. SINGAPORE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2018-2030 (USD MILLION)
TABLE 195. SINGAPORE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 196. SINGAPORE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 197. SINGAPORE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 198. SINGAPORE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
TABLE 199. SINGAPORE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 200. SINGAPORE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 201. SOUTH KOREA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 202. SOUTH KOREA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
TABLE 203. SOUTH KOREA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 204. SOUTH KOREA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2018-2030 (USD MILLION)
TABLE 205. SOUTH KOREA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 206. SOUTH KOREA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 207. SOUTH KOREA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 208. SOUTH KOREA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
TABLE 209. SOUTH KOREA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 210. SOUTH KOREA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 211. TAIWAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 212. TAIWAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
TABLE 213. TAIWAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 214. TAIWAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2018-2030 (USD MILLION)
TABLE 215. TAIWAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 216. TAIWAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 217. TAIWAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 218. TAIWAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
TABLE 219. TAIWAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 220. TAIWAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 221. THAILAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 222. THAILAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
TABLE 223. THAILAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 224. THAILAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2018-2030 (USD MILLION)
TABLE 225. THAILAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 226. THAILAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 227. THAILAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 228. THAILAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
TABLE 229. THAILAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 230. THAILAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 231. VIETNAM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 232. VIETNAM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
TABLE 233. VIETNAM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 234. VIETNAM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2018-2030 (USD MILLION)
TABLE 235. VIETNAM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 236. VIETNAM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 237. VIETNAM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 238. VIETNAM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
TABLE 239. VIETNAM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 240. VIETNAM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2018-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 252. DENMARK CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 253. DENMARK CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
TABLE 254. DENMARK CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 255. DENMARK CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2018-2030 (USD MILLION)
TABLE 256. DENMARK CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 257. DENMARK CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 258. DENMARK CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 259. DENMARK CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
TABLE 260. DENMARK CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 261. DENMARK CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 262. EGYPT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 263. EGYPT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
TABLE 264. EGYPT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 265. EGYPT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2018-2030 (USD MILLION)
TABLE 266. EGYPT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 267. EGYPT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 268. EGYPT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 269. EGYPT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
TABLE 270. EGYPT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 271. EGYPT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 272. FINLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 273. FINLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
TABLE 274. FINLAND CARTILAGE REPAIR/CAR

Companies Mentioned

  • Anika Therapeutics Inc.
  • Arthrex, Inc.
  • B. Braun SE
  • BioTissue, Inc.
  • Bioventus
  • Collagen Solutions Ltd.
  • CollPlant Biotechnologies Ltd.
  • CONMED Corporation
  • Episurf Medical AB
  • Geistlich Pharma AG
  • Integra LifeSciences Corporation
  • Isto Biologics Inc
  • Johnson & Johnson Services, Inc.
  • Kolon TissueGene, Inc.
  • MEDIPOST Co., Ltd.
  • Mesoblast Limited
  • Ocugen, Inc.
  • Orthocell Ltd.
  • Regrow Biosciences Pvt Ltd.
  • RTI Surgical, Inc.
  • Smith & Nephew PLC
  • Stryker Corporation
  • Vericel Corporation
  • Zimmer Biomet Holdings, Inc.

Methodology

Loading
LOADING...

Table Information